Related Experiment Videos
Biology of TGF-beta in knockout and transgenic mouse models
E P Böttinger1, J J Letterio, A B Roberts
1Laboratory of Chemoprevention, National Cancer Institute, Bethesda, Maryland, USA.
Abstract:
This paper reviews the basic biology and biochemistry of the TGF-beta isoforms including their unique serine-threonine receptors and signaling intermediates. Dysregulation of TGF-beta expression and/or receptor/signaling function have been implicated in a wide variety of pathologies. We will discuss mechanisms underlying some of these disease processes as gained from study of transgenic mice in which expression of TGF-beta 1 has either been lost by targeted deletion of its gene, is overexpressed in a tissue-specific manner, or blocked by its latency associated peptide.
Insights
This review covers the biology of transforming growth factor-beta (TGF-beta) isoforms, their receptors, and signaling pathways. Studies using genetically modified mice reveal how TGF-beta dysregulation contributes to various diseases.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Signaling
Background:
- Transforming growth factor-beta (TGF-beta) is a crucial cytokine involved in cellular processes.
- TGF-beta signaling pathways are complex, involving specific receptors and intracellular intermediates.
- Aberrant TGF-beta signaling is linked to numerous pathological conditions.
Purpose of the Study:
- To review the fundamental biology and biochemistry of TGF-beta isoforms.
- To explore the mechanisms by which TGF-beta dysregulation contributes to disease.
- To discuss findings from transgenic mouse models investigating TGF-beta 1 function.
Main Methods:
- Review of existing literature on TGF-beta biology and signaling.
- Analysis of data from transgenic mouse models with altered TGF-beta 1 expression or function.
- Investigation of TGF-beta 1 gene deletion, tissue-specific overexpression, and latency-associated peptide blockade.
Main Results:
- TGF-beta isoforms utilize distinct serine-threonine receptors and signaling intermediates.
- Dysregulation in TGF-beta expression or signaling is implicated in diverse pathologies.
- Transgenic mouse studies provide insights into disease mechanisms driven by TGF-beta 1 alterations.
Conclusions:
- Understanding TGF-beta biology and signaling is critical for deciphering disease pathogenesis.
- Genetically engineered mouse models are valuable tools for studying TGF-beta's role in health and disease.
- Targeting TGF-beta pathways holds potential for therapeutic interventions in various diseases.